Form 3 Filing for Belite Bio, Inc. - Ownership Change

This filing details changes in beneficial ownership for Belite Bio, Inc. (BLTE), specifically concerning Dr. Hendrik Peter Scholl, the Chief Medical Officer. The report includes information on stock options granted to Dr. Scholl, with vesting schedules and exercise prices detailed in footnotes. These options are for the company's Ordinary Shares and are held indirectly through Bioptima Ltd. The filing also includes a Power of Attorney document, appointing specific individuals to act on Dr. Scholl's behalf for SEC reporting purposes, including managing EDGAR filings and obtaining necessary credentials. This power of attorney authorizes the appointed individuals to prepare, execute, and file various SEC forms, including Forms 3, 4, 5, Schedules 13D/13G, and Form 144, on behalf of Dr. Scholl. The document clarifies that the appointed attorneys-in-fact are serving at Dr. Scholl's request and do not assume liability for his compliance with SEC regulations, though he remains responsible for fulfilling his reporting obligations.